A core trimer of the paramyxovirus fusion protein: Parallels to influenza virus hemagglutinin and HIV-1 gp41

Virology

Volumn 248, Issue 1, 1998, Pages 20-34

  Joshi, Sangeeta Bagai ^a   Dutch, Rebecca Ellis ^a   Lamb, Robert A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 41; HYBRID PROTEIN; INFLUENZA VIRUS HEMAGGLUTININ;

AMINO ACID COMPOSITION; ARTICLE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; GENE CONSTRUCT; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS; MASS SPECTROMETRY; MEMBRANE FUSION; MOLECULAR WEIGHT; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION;

EID: 0032529672     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9242     Document Type: Article

References (66)

1. Asano K., Asano A. Why is a specific amino acid sequence of F glycoprotein required for the membrane fusion reaction between envelope of HVJ (Sendai virus) and target cell membranes. Biochem. Int. 10:1985;115-122.
2. Bagai S., Lamb R. A. Quantitative measurement of paramyxovirus fusion: Differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J. Virol. 69:1995;6712-6719.
3. Bagai S., Lamb R. A. Truncation of the COOH-terminal region of the paramyxovirus SV5 fusion protein leads to hemifusion but not complete fusion. J. Cell Biol. 135:1996;73-84.
4. Bagai S., Lamb R. A. A glycine to alanine substitution in the paramyxovirus SV5 fusion peptide increases the initial rate of fusion. Virology. 238:1997;283-290.
5. Blacklow S. C., Lu M., Kim P. S. A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry. 34:1995;14956-14962.
6. Buckland R., Malvoisin E., Beauverger P., Wild F. A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J. Gen. Virol. 73:1992;1703-1707.
7. Bullough P. A., Hughson F. M., Skehel J. J., Wiley D. C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature. 371:1994;37-43.
8. Carr C. M., Chaudhry C., Kim P. S. Influenza hemagglutinin is spring- loaded by a metastable native conformation. Proc. Natl. Acad. Sci. USA. 94:1997;14306-14313.
9. Carr C. M., Kim P. S. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell. 73:1993;823-832.
10. Chambers P., Pringle C. R., Easton A. J. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J. Gen. Virol. 71:1990;3075-3080.
11. Chan D. C., Fass D., Berger J. M., Kim P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89:1997;263-273.
12. Chernomordik L. V., Leikina E., Frolov V., Bronk P., Zimmerberg J. An early stage of membrane fusion mediated by the low pH conformation of influenza hemagglutinin depends upon membrane lipids. J. Cell Biol. 136:1997;81-93.
13. Damico R. L., Crane J., Bates P. Receptor-triggered membrane association of a model retroviral glycoprotein. Proc. Natl. Acad. Sci. USA. 95:1998;2580-2585.
14. Fass D., Harrison S. C., Kim P. S. Retrovirus envelope domain at 1.7Å resolution. Nat. Struct. Biol. 3:1996a;465-469.
15. Fass D., Harrison S. C., Kim P. S. Structure of Moloney murine virus envelope domain at 1.7Å resolution. Nat. Struct. Biol. 3:1996b;465-469.
16. Fass D., Kim P. S. Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin. Curr. Biol. 5:1995;1377-1383.
17. Frangioni J. V., Neel B. G. Solubilization and purification of enzymatically active glutathioneS. Anal. Biochem. 210:1993;179-187.
18. 7. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
19. Ghosh J. K., Ovadia M., Shai Y. A leucine zipper motif in the ectodomain of Sendai virus fusion protein assembles in solution and in membranes and specifically binds biologically-active peptides and the virus. Biochemistry. 36:1997;15451-15462.
20. Gill S. C., von Hippel P. H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:1989;319-326.
21. Hart T. S., Kirsh R., Ellens H., Sweet R. W., Lambert D. M., Petteway S. R., Leary J., Bugelski P. J. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA. 88:1991;2189-2193.
22. Hernandez L. D., Hoffman L. R., Wolfsberg T. G., White J. M. Virus-cell and cell-cell fusion. Annu. Rev. 12:1996;627-661.
23. Hernandez L. D., Peters R. J., Delos S. E., Young J. A. T., Agard D. A., White J. M. Activation of a retroviral membrane fusion protein: Soluble receptor-induced liposome binding of the ALSV envelope glycoprotein. J. Cell Biol. 139:1997;1455-1464.
24. Horvath C. M., Lamb R. A. Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: Roles of conserved residues in cell fusion. J. Virol. 66:1992;2443-2455.
25. Hughson F. M. Enveloped viruses: A common mode of membrane fusion. Curr. Biol. 7:1997;R565-R569.
26. Hunter, E. 1997, Viral entry and receptors, In, Retroviruses, 71, 119, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
27. Jiang S., Lin K., Strick N., Neurath A. R. HIV-1 inhibition by a peptide [letter]. Nature. 365:1993a;113.
28. Jiang S., Lin K., Strick N., Neurath A. R. Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41. Biochem. Biophys. Res. Commun. 195:1993b;533-538.
29. Judice J. K., Tom J. Y. K., Huang W., Wrin T., Vennari J., Petropoulos C. J., McDowell R. S. Inhibition of HIV type 1 infectivity by constrained α-helical peptides: Implications for the viral fusion mechanism. Proc. Natl. Acad. Sci. USA. 94:1997;13426-13430.
30. Klenk H.-D., Garten W. Host cell proteases controlling virus pathogenicity. Trends Microbiol. 2:1994;39-43.
31. Lamb R. A. Paramyxovirus fusion: A hypothesis for changes. Virology. 197:1993;1-11.
32. Lamb, R. A. Kolakofsky, D. 1996, Paramyxoviridae, In, Virology, B. N. FieldsD. M. KnipeP. M. Howley, 1177, 1204, Raven Press, New York.
33. Lambert D. M., Barney S., Lambert A. L., Guthrie K., Medinas R., Davis D. E., T. B., Erickson J., Merutka G., Pettaway S. R. Jr. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA. 93:1996;2186-2191.
34. Lu M., Blacklow S. C., Kim P. S. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2:1995;1075-1082.
35. Moore J. P., McKeating J. A., Weiss R. A., Sattentau Q. J. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science. 250:1990;1130-1142.
36. Morris S. J., Sarkar D. P., White J. M., Blumenthal R. Kinetics of pH- dependent fusion between 3T3 fibroblasts expressing influenza hemagglutinin and red blood cells. J. Biol. Chem. 264:1989;3972-3978.
37. Munoz-Barroso I., Durell S., Sakaguchi K., Appella E., Blumenthal R. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J. Cell Biol. 140:1998;315-323.
38. Nehete P. N., Arlinghaus R. B., Sastry K. J. Inhibition of human immunodeficiency virus type 1 infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120. J. Virol. 67:1993;6841-6846.
39. Novick S. L., Hoekstra D. Membrane penetration of Sendai virus glycoproteins during the early stage of fusion with liposomes as determined by hydrophobic affinity labeling. Proc. Natl. Acad. Sci. USA. 85:1988;7433-7437.
40. Nussbaum O., Broder C. C., Berger E. A. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68:1994;5411-5422.
41. Paterson R. G., Harris T. J. R., Lamb R. A. Analysis and gene assignment of mRNAs of a paramyxovirus, simian virus 5. Virology. 138:1984a;310-323.
42. Paterson R. G., Harris T. J. R., Lamb R. A. Fusion protein of the paramyxovirus simian virus 5: Nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc. Natl. Acad. Sci. USA. 81:1984b;6706-6710.
43. Paterson R. G., Hiebert S. W., Lamb R. A. Expression at the cell surface of biologically active fusion and hemagglutinin-neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc. Natl. Acad. Sci. USA. 82:1985;7520-7524.
44. Paterson, R. G. Lamb, R. A. 1993, The molecular biology of influenza viruses and paramyxoviruses, In, Molecular Virology: A Practical Approach, A. DavidsonR. M. Elliott, 35, 73, IRL Oxford University Press, Oxford.
45. Rapaport D., Ovadia M., Shai Y. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: An emerging similarity with functional domains of other viruses. EMBO J. 14:1995;5524-5531.
46. Rose J. K., Buonocore L., Whitt M. A. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechnology. 10:1991;520-525.
47. Ruigrok R. W. H., Martin S. R., Wharton S. A., Skehel J. J., Bayley P. M., Wiley D. C. Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes. Virology. 155:1986;484-497.
48. Russell R., Paterson R. G., Lamb R. A. Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein. Virology. 199:1994;160-168.
49. Schagger H., Von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of protein in the range from 1 to 100 kDa. Anal. Biochem. 166:1987;368-379.
50. Scheid A., Choppin P. W. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology. 57:1974;475-490.
51. Scholtz J. M., Qian H., York E. J., Stewart J. M., Baldwin R. L. Parameters of helix-coil transition theory for alanine-based peptides of varying chain lengths in water. Biopolymers. 31:1991;1463-1470.
52. Schuster, T. M. Laue, T. M. 1994, Modern Analytical Ultracentrifugation, Birhauser, Boston, MA.
53. Sergel-German T., McQuain C., Morrison T. Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. J. Virol. 68:1994;7654-7658.
54. Slepushkin V. A., Kornilaeva G. V., Andreev S. M., Sidorova M. V., Petrukhina A. O., Matsevich G. R., Raduk S. V., Grigoriev V. B., Makarova T. V., Lukashov V. V. Inhibition of human immunodeficiency virus type 1 (HIV-1) penetration into target cells by synthetic peptides mimicking the N-terminus of the HIV-1 transmembrane glycoprotein. Virology. 194:1993;294-301.
55. Storrs R. W., Truckses D., Wemmer D. E. Helix propagation in trifluoroethanol solutions. Biopolymers. 32:1992;1695-1702.
56. Tan K., Liu J.-H., Wang J.-H., Shen S., Lu M. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc. Natl. Acad. Sci. USA. 94:1997;12303-12308.
57. Weissenhorn W., Dessen A., Harrison S. C., Skehel J. J., Wiley D. C. Atomic structure of the ectodomain from HIV-1 gp41. Nature. 387:1997;426-430.
58. Wharton S. A., Calder L. J., Ruigrok R. W. H., Skehel J. J., Steinhauer D. A., Wiley D. C. Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. EMBO J. 14:1995;240-246.
59. Wild C., Dubay J. W., Greenwell T., Baird T. Jr., Oas T. G., McDanal C., Hunter E., Matthews T. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl. Acad. Sci. USA. 91:1994a;12676-12680.
60. Wild C., Oas T., McDanal C., Bolognesi D., Matthews T. A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA. 89:1992;10537-10541.
61. Wild C. T., Shugars D. C., Greenwell T. K., McDanal C. B., Matthews T. J. Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA. 91:1994b;9770-9774.
62. Wiley D. C., Skehel J. J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56:1987;365-394.
63. Wilson I. A., Skehel J. J., Wiley D. C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature. 289:1981;366-375.
64. Yao Q., Compans R. W. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology. 223:1996;103-112.
65. Young J. K., Hicks R. P., Wright G. E., Morrison T. G. Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling. Virology. 238:1997;291-304.
66. Zhou J., Dutch R. E., Lamb R. A. Proper spacing between heptad repeat B and the transmembrane domain boundary of the paramyxovirus SV5 F protein is critical for biological activity. Virology. 239:1997;327-339.